Diater

Founded in 1999 by the current management team, it is a company specialized in the development and commercialization of diagnostic and immunotherapy treatment products for allergic conditions, with a large catalogue of products, including the production of self-vaccines for bacterial conditions. With a staff of over 100 employees and over 55,000 patients treated each year, Diater is one of the leading companies in Spain and a point of reference at an international level, with a proven reputation as an innovative company which has been able to develop numerous R&D initiatives, creating a unique portfolio of biopharmaceutical products on the market.

In 2016, Nazca sold the company to Wessanen, a Dutch company leading the European market for organic food.